These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7905732)

  • 1. Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors.
    Musgrave IF; Seifert R
    Biochem Pharmacol; 1994 Jan; 47(2):233-9. PubMed ID: 7905732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium.
    Musgrave IF; Seifert R
    Biochem Pharmacol; 1995 Jan; 49(2):187-96. PubMed ID: 7530955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the alpha 2/beta-adrenoceptor-coupled adenylate cyclase system and their relationship with adrenergic responsiveness in hamster fat cells from different anatomical sites.
    Dieudonne MN; Pecquery R; Giudicelli Y
    Eur J Biochem; 1992 Apr; 205(2):867-73. PubMed ID: 1349284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K; Seifert R
    J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postjunctional alpha(2C)-adrenoceptor contractility in human saphenous vein.
    Rizzo CA; Ruck LM; Corboz MR; Umland SP; Wan Y; Shah H; Jakway J; Cheng L; McCormick K; Egan RW; Hey JA
    Eur J Pharmacol; 2001 Feb; 413(2-3):263-9. PubMed ID: 11226402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
    Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superoxide production.
    Krautwurst D; Seifert R; Hescheler J; Schultz G
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1025-35. PubMed ID: 1281979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopeptides activate Gi-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells.
    Klinker JF; Höer A; Schwaner I; Offermanns S; Wenzel-Seifert K; Seifert R
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):245-51. PubMed ID: 8250850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
    Trendelenburg AU; Wahl CA; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):245-9. PubMed ID: 8692278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
    Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
    Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete functional differentiation of HL-60 leukemic cells by synthetic lipopeptides. Partial inhibition by pertussis toxin of enhanced superoxide formation.
    Seifert R; Serke S; Huhn D; Bessler WG; Hauschildt S; Metzger J; Wismüller KH; Jung G
    Eur J Biochem; 1992 Jan; 203(1-2):143-51. PubMed ID: 1309696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
    Remaury A; Paris H
    J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants.
    Klinker JF; Schwaner I; Offermanns S; Hagelüken A; Seifert R
    Biochem Pharmacol; 1994 Nov; 48(10):1857-64. PubMed ID: 7986196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype.
    Arnsten AF; Leslie FM
    Neuropharmacology; 1991 Dec; 30(12A):1279-89. PubMed ID: 1686301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal responses to noradrenaline in the cerebral cortex: evidence against the involvement of alpha 2-adrenoceptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1984 Jun; 82(2):453-8. PubMed ID: 6145471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
    Seifert R; Hagelüken A; Höer A; Höer D; Grünbaum L; Offermanns S; Schwaner I; Zingel V; Schunack W; Schultz G
    Mol Pharmacol; 1994 Apr; 45(4):578-86. PubMed ID: 7514261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.